IDH mutations were first reported in GBM and were later found in other tumors, such as AML, cholangiocarcinoma, and chondrosarcoma (Parsons et al., 2008; Marcucci et al., 2010; Amary et al., 2011; Borger et al., 2012). This evidence concerns the gene IDH1 and acute myeloid leukemia.